Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

BD CD64 APC-R700 Recalled by Becton, Dickinson and Company, BD Biosciences Due to Three lots of CD64 (MD22) are contaminated with...

Date: October 30, 2015
Company: Becton, Dickinson and Company, BD Biosciences
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Becton, Dickinson and Company, BD Biosciences directly.

Affected Products

BD CD64 APC-R700; Analyte Specific Reagent; Model 657701; Lot No. 4344945, 5037611 and 5063945. Hematology - used as analyte specific reagent - contamination leads to possibility of unexpected staining pattern.

Quantity: 23 vials

Why Was This Recalled?

Three lots of CD64 (MD22) are contaminated with CD4 antibody.

Where Was This Sold?

This product was distributed to 9 states: FL, GA, IL, IA, ND, PA, RI, TX, WA

Affected (9 states)Not affected

About Becton, Dickinson and Company, BD Biosciences

Becton, Dickinson and Company, BD Biosciences has 35 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report